Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sleep Wake Disorders 1 Recurrence 1 Prostatic Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Hematologic Neoplasms 1 Brain Neoplasms 1

Interventions

Radiosurgery 23 Temozolomide 14 Magnetic Resonance Spectroscopy 14 pembrolizumab 11 Bevacizumab 11 Nivolumab 10 Ipilimumab 8 Memantine 7 Specimen Handling 6 abemaciclib 5 Radiotherapy 5 Mental Status and Dementia Tests 5 Blood Specimen Collection 5 Radiation 4 entrectinib 3 Surveys and Questionnaires 3 Sodium Chloride 3 Saline Solution 3 Receptors, Interleukin-8B 3 Proton Therapy 3 Lomustine 3 trastuzumab deruxtecan 2 trametinib 2 pertuzumab 2 osimertinib 2 lenvatinib 2 fluciclovine F-18 2 contrast agent BR1 2 atezolizumab 2 Watchful Waiting 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Brain Neoplasms × Methylphenidate × 90 days × Clear all

NCT06905587 2026-04-23

EMBRAIN

Odense University Hospital

Phase 3 Recruiting

Brain Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡